PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING GRAFT VERSUS HOST DISEASE COMPRISING THIAMINE DERIVATIVES
The present invention relates to a pharmaceutical composition for preventing, treating, or ameliorating graft versus host disease (GVHD), comprising thiamine derivatives, in which the active ingredient of the pharmaceutical composition is fursultiamine, which can alleviate weight loss found in patie...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
05.10.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a pharmaceutical composition for preventing, treating, or ameliorating graft versus host disease (GVHD), comprising thiamine derivatives, in which the active ingredient of the pharmaceutical composition is fursultiamine, which can alleviate weight loss found in patients with GVHD, reduce the infiltration of liver and colon inflammatory cells, and effectively inhibit the production of allogeneic CD4+ IFNγ+ T cells, and thus can be effectively used for the prevention, treatment, or amelioration of GVHD. |
---|---|
Bibliography: | Application Number: US202118025252 |